ID   SO2A1_RAT               Reviewed;         644 AA.
AC   Q00910;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   16-NOV-2011, sequence version 3.
DT   29-MAY-2024, entry version 147.
DE   RecName: Full=Solute carrier organic anion transporter family member 2A1 {ECO:0000305};
DE            Short=SLCO2A1;
DE   AltName: Full=Matrin F/G 1 {ECO:0000303|PubMed:7754369};
DE   AltName: Full=OATP2A1;
DE   AltName: Full=PHOAR2;
DE   AltName: Full=Prostaglandin transporter {ECO:0000303|PubMed:15044627, ECO:0000303|PubMed:7754369};
DE            Short=PGT {ECO:0000303|PubMed:15044627, ECO:0000303|PubMed:15855165, ECO:0000303|PubMed:20346915, ECO:0000303|PubMed:7754369};
DE   AltName: Full=Solute carrier family 21 member 2;
DE            Short=SLC21A2;
GN   Name=Slco2a1 {ECO:0000312|RGD:3051}; Synonyms=Matr1, Slc21a2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Liver;
RX   PubMed=2068100; DOI=10.1073/pnas.88.14.6186;
RA   Hakes D.J., Berezney R.;
RT   "Molecular cloning of matrin F/G: a DNA binding protein of the nuclear
RT   matrix that contains putative zinc finger motifs.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:6186-6190(1991).
RN   [2]
RP   CHARACTERIZATION, FUNCTION, AND TRANSPORTER ACTIVITY.
RX   PubMed=7754369; DOI=10.1126/science.7754369;
RA   Kanai N., Lu R., Satriano J.A., Bao Y., Wolkoff A.W., Schuster V.L.;
RT   "Identification and characterization of a prostaglandin transporter.";
RL   Science 268:866-869(1995).
RN   [3]
RP   FUNCTION, AND TRANSPORTER ACTIVITY.
RC   TISSUE=Lung;
RX   PubMed=10484490; DOI=10.1152/ajpregu.1999.277.3.r734;
RA   Pucci M.L., Bao Y., Chan B., Itoh S., Lu R., Copeland N.G., Gilbert D.J.,
RA   Jenkins N.A., Schuster V.L.;
RT   "Cloning of mouse prostaglandin transporter PGT cDNA: species-specific
RT   substrate affinities.";
RL   Am. J. Physiol. 277:R734-R741(1999).
RN   [4]
RP   FUNCTION, AND TRANSPORTER ACTIVITY.
RX   PubMed=11880322; DOI=10.1152/ajprenal.00150.2001;
RA   Endo S., Nomura T., Chan B.S., Lu R., Pucci M.L., Bao Y., Schuster V.L.;
RT   "Expression of PGT in MDCK cell monolayers: polarized apical localization
RT   and induction of active PG transport.";
RL   Am. J. Physiol. 282:F618-F622(2002).
RN   [5]
RP   FUNCTION, TRANSPORTER ACTIVITY, TISSUE SPECIFICITY, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=11997327; DOI=10.1152/ajprenal.00152.2001;
RA   Bao Y., Pucci M.L., Chan B.S., Lu R., Ito S., Schuster V.L.;
RT   "Prostaglandin transporter PGT is expressed in cell types that synthesize
RT   and release prostanoids.";
RL   Am. J. Physiol. 282:F1103-F1110(2002).
RN   [6]
RP   FUNCTION, AND TRANSPORTER ACTIVITY.
RX   PubMed=15044627; DOI=10.1124/mol.65.4.973;
RA   Nomura T., Lu R., Pucci M.L., Schuster V.L.;
RT   "The two-step model of prostaglandin signal termination: in vitro
RT   reconstitution with the prostaglandin transporter and prostaglandin 15
RT   dehydrogenase.";
RL   Mol. Pharmacol. 65:973-978(2004).
RN   [7]
RP   FUNCTION, TRANSPORTER ACTIVITY, AND SUBCELLULAR LOCATION.
RX   PubMed=15855165; DOI=10.1074/jbc.m408286200;
RA   Nomura T., Chang H.Y., Lu R., Hankin J., Murphy R.C., Schuster V.L.;
RT   "Prostaglandin signaling in the renal collecting duct: release, reuptake,
RT   and oxidation in the same cell.";
RL   J. Biol. Chem. 280:28424-28429(2005).
RN   [8]
RP   FUNCTION, TRANSPORTER ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=20346915; DOI=10.1016/j.bbrc.2010.03.108;
RA   Chi Y., Schuster V.L.;
RT   "The prostaglandin transporter PGT transports PGH(2).";
RL   Biochem. Biophys. Res. Commun. 395:168-172(2010).
CC   -!- FUNCTION: Mediates the transport of prostaglandins (PGs, mainly PGE2,
CC       PGE1, PGE3, PGF2alpha, PGD2, PGH2) and thromboxanes (thromboxane B2)
CC       across the cell membrane (PubMed:10484490, PubMed:11880322,
CC       PubMed:11997327, PubMed:15044627, PubMed:15855165, PubMed:20346915,
CC       PubMed:7754369). PGs and thromboxanes play fundamental roles in diverse
CC       functions such as intraocular pressure, gastric acid secretion, renal
CC       salt and water transport, vascular tone, and fever (PubMed:15044627).
CC       Plays a role in the clearance of PGs from the circulation through
CC       cellular uptake, which allows cytoplasmic oxidation and PG signal
CC       termination (PubMed:11997327, PubMed:15044627, PubMed:7754369). PG
CC       uptake is dependent upon membrane potential and involves exchange of a
CC       monovalent anionic substrate (PGs exist physiologically as an anionic
CC       monovalent form) with a stoichiometry of 1:1 for divalent anions or of
CC       1:2 for monovalent anions (By similarity). Uses lactate, generated by
CC       glycolysis, as a counter-substrate to mediate PG influx and efflux
CC       (PubMed:11997327). Under nonglycolytic conditions, metabolites other
CC       than lactate might serve as counter-substrates (PubMed:11997327).
CC       Although the mechanism is not clear, this transporter can function in
CC       bidirectional mode (By similarity). When apically expressed in
CC       epithelial cells, it facilitates transcellular transport (also called
CC       vectorial release), extracting PG from the apical medium and
CC       facilitating transport across the cell toward the basolateral side,
CC       whereupon the PG exits the cell by simple diffusion (PubMed:11880322,
CC       PubMed:15044627, PubMed:15855165). In the renal collecting duct,
CC       regulates renal Na+ balance by removing PGE2 from apical medium (PGE2
CC       EP4 receptor is likely localized to the luminal/apical membrane and
CC       stimulates Na+ resorption) and transporting it toward the basolateral
CC       membrane (where PGE2 EP1 and EP3 receptors inhibit Na+ resorption)
CC       (PubMed:15855165). Plays a role in endometrium during decidualization,
CC       increasing uptake of PGs by decidual cells (By similarity). Involved in
CC       critical events for ovulation (By similarity). Regulates extracellular
CC       PGE2 concentration for follicular development in the ovaries (By
CC       similarity). Expressed intracellularly, may contribute to vesicular
CC       uptake of newly synthesized intracellular PGs, thereby facilitating
CC       exocytotic secretion of PGs without being metabolized (By similarity).
CC       Essential core component of the major type of large-conductance anion
CC       channel, Maxi-Cl, which plays essential roles in inorganic anion
CC       transport, cell volume regulation and release of ATP and glutamate not
CC       only in physiological processes but also in pathological processes (By
CC       similarity). May contribute to regulate the transport of organic
CC       compounds in testis across the blood-testis-barrier (By similarity).
CC       {ECO:0000250|UniProtKB:Q92959, ECO:0000250|UniProtKB:Q9EPT5,
CC       ECO:0000269|PubMed:10484490, ECO:0000269|PubMed:11880322,
CC       ECO:0000269|PubMed:11997327, ECO:0000269|PubMed:15044627,
CC       ECO:0000269|PubMed:15855165, ECO:0000269|PubMed:20346915,
CC       ECO:0000269|PubMed:7754369, ECO:0000303|PubMed:11997327,
CC       ECO:0000303|PubMed:15044627}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=prostaglandin E2(out) = prostaglandin E2(in);
CC         Xref=Rhea:RHEA:50984, ChEBI:CHEBI:606564;
CC         Evidence={ECO:0000250|UniProtKB:Q9EPT5};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2 (S)-lactate(in) + prostaglandin H2(out) = 2 (S)-lactate(out)
CC         + prostaglandin H2(in); Xref=Rhea:RHEA:74379, ChEBI:CHEBI:16651,
CC         ChEBI:CHEBI:57405; Evidence={ECO:0000269|PubMed:20346915};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2 (S)-lactate(in) + prostaglandin E2(out) = 2 (S)-lactate(out)
CC         + prostaglandin E2(in); Xref=Rhea:RHEA:74383, ChEBI:CHEBI:16651,
CC         ChEBI:CHEBI:606564; Evidence={ECO:0000269|PubMed:10484490,
CC         ECO:0000269|PubMed:11880322, ECO:0000269|PubMed:11997327,
CC         ECO:0000269|PubMed:15044627, ECO:0000305|PubMed:7754369};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2 (S)-lactate(in) + prostaglandin E1(out) = 2 (S)-lactate(out)
CC         + prostaglandin E1(in); Xref=Rhea:RHEA:74395, ChEBI:CHEBI:16651,
CC         ChEBI:CHEBI:57397; Evidence={ECO:0000250|UniProtKB:Q92959};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2 (S)-lactate(in) + prostaglandin F2alpha(out) = 2 (S)-
CC         lactate(out) + prostaglandin F2alpha(in); Xref=Rhea:RHEA:74399,
CC         ChEBI:CHEBI:16651, ChEBI:CHEBI:57404;
CC         Evidence={ECO:0000250|UniProtKB:Q92959};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2 (S)-lactate(in) + prostaglandin D2(out) = 2 (S)-lactate(out)
CC         + prostaglandin D2(in); Xref=Rhea:RHEA:74403, ChEBI:CHEBI:16651,
CC         ChEBI:CHEBI:57406; Evidence={ECO:0000250|UniProtKB:Q92959};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2 (S)-lactate(in) + thromboxane B2(out) = 2 (S)-lactate(out) +
CC         thromboxane B2(in); Xref=Rhea:RHEA:74407, ChEBI:CHEBI:16651,
CC         ChEBI:CHEBI:90696; Evidence={ECO:0000250|UniProtKB:Q92959};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2 (S)-lactate(in) + prostaglandin E3(out) = 2 (S)-lactate(out)
CC         + prostaglandin E3(in); Xref=Rhea:RHEA:74351, ChEBI:CHEBI:16651,
CC         ChEBI:CHEBI:133132; Evidence={ECO:0000250|UniProtKB:Q92959};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=91.0 nM for PGE2 {ECO:0000269|PubMed:20346915};
CC         KM=376.0 nM for PGH2 {ECO:0000269|PubMed:20346915};
CC         Vmax=0.284 nmol/h/mg protein with PGE2 {ECO:0000269|PubMed:20346915};
CC         Vmax=0.757 nmol/h/mg protein with PGH2 {ECO:0000269|PubMed:20346915};
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:11997327,
CC       ECO:0000269|PubMed:15855165, ECO:0000305|PubMed:7754369}; Multi-pass
CC       membrane protein {ECO:0000255}. Basal cell membrane
CC       {ECO:0000250|UniProtKB:Q92959}; Multi-pass membrane protein
CC       {ECO:0000255}. Cytoplasm {ECO:0000269|PubMed:11997327}. Lysosome
CC       {ECO:0000250|UniProtKB:Q9EPT5}. Note=In kidney cells, it localizes in
CC       cytoplasmic domains. {ECO:0000269|PubMed:11997327}.
CC   -!- TISSUE SPECIFICITY: Expressed in kidney and platelets.
CC       {ECO:0000269|PubMed:11997327}.
CC   -!- SIMILARITY: Belongs to the organo anion transporter (TC 2.A.60) family.
CC       {ECO:0000305}.
CC   -!- CAUTION: Was originally thought to be a nuclear DNA-binding protein.
CC       {ECO:0000305|PubMed:2068100}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA41574.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAA41574.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M64862; AAA41574.1; ALT_SEQ; mRNA.
DR   PIR; A41120; A41120.
DR   AlphaFoldDB; Q00910; -.
DR   SMR; Q00910; -.
DR   STRING; 10116.ENSRNOP00000069382; -.
DR   BindingDB; Q00910; -.
DR   ChEMBL; CHEMBL2073680; -.
DR   GuidetoPHARMACOLOGY; 1223; -.
DR   SwissLipids; SLP:000001648; -.
DR   TCDB; 2.A.60.1.2; the organo anion transporter (oat) family.
DR   GlyCosmos; Q00910; 4 sites, No reported glycans.
DR   GlyGen; Q00910; 4 sites.
DR   PhosphoSitePlus; Q00910; -.
DR   PaxDb; 10116-ENSRNOP00000012162; -.
DR   PeptideAtlas; Q00910; -.
DR   AGR; RGD:3051; -.
DR   RGD; 3051; Slco2a1.
DR   eggNOG; KOG3626; Eukaryota.
DR   InParanoid; Q00910; -.
DR   Reactome; R-RNO-879518; Transport of organic anions.
DR   PRO; PR:Q00910; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0009925; C:basal plasma membrane; ISS:UniProtKB.
DR   GO; GO:0016323; C:basolateral plasma membrane; IBA:GO_Central.
DR   GO; GO:0005764; C:lysosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0015132; F:prostaglandin transmembrane transporter activity; ISO:RGD.
DR   GO; GO:0015347; F:sodium-independent organic anion transmembrane transporter activity; IBA:GO_Central.
DR   GO; GO:0015732; P:prostaglandin transport; ISO:RGD.
DR   GO; GO:0043252; P:sodium-independent organic anion transport; IBA:GO_Central.
DR   CDD; cd17461; MFS_SLCO2A_OATP2A; 1.
DR   Gene3D; 3.30.60.30; -; 1.
DR   Gene3D; 1.20.1250.20; MFS general substrate transporter like domains; 1.
DR   InterPro; IPR002350; Kazal_dom.
DR   InterPro; IPR036058; Kazal_dom_sf.
DR   InterPro; IPR020846; MFS_dom.
DR   InterPro; IPR036259; MFS_trans_sf.
DR   InterPro; IPR004156; OATP.
DR   NCBIfam; TIGR00805; oat; 1.
DR   PANTHER; PTHR11388; ORGANIC ANION TRANSPORTER; 1.
DR   PANTHER; PTHR11388:SF14; SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY MEMBER 2A1; 1.
DR   Pfam; PF07648; Kazal_2; 1.
DR   Pfam; PF03137; OATP; 1.
DR   SUPFAM; SSF100895; Kazal-type serine protease inhibitors; 1.
DR   SUPFAM; SSF103473; MFS general substrate transporter; 1.
DR   PROSITE; PS51465; KAZAL_2; 1.
DR   PROSITE; PS50850; MFS; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Cytoplasm; Disulfide bond; Glycoprotein; Lipid transport;
KW   Lysosome; Membrane; Reference proteome; Transmembrane; Transmembrane helix;
KW   Transport.
FT   CHAIN           1..644
FT                   /note="Solute carrier organic anion transporter family
FT                   member 2A1"
FT                   /id="PRO_0000191060"
FT   TRANSMEM        27..47
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        71..91
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        101..121
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        172..192
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        210..230
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        258..278
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        321..341
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        365..385
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        399..419
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        511..531
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        551..571
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        606..626
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          438..496
FT                   /note="Kazal-like"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00798"
FT   REGION          1..20
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   CARBOHYD        134
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        478
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        491
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        639
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        444..474
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00798"
FT   DISULFID        450..470
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00798"
FT   DISULFID        459..494
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00798"
SQ   SEQUENCE   644 AA;  70387 MW;  143841277CC95F85 CRC64;
     MGLLLKPGAR QGSGTSSVPD RRCPRSVFSN IKVFVLCHGL LQLCQLLYSA YFKSSLTTIE
     KRFGLSSSSS GLISSLNEIS NATLIIFISY FGSRVNRPRM IGIGGLLLAA GAFVLTLPHF
     LSEPYQYTST TDGNRSSFQT DLCQKHFGAL PPSKCHSTVP DTHKETSSLW GLMVVAQLLA
     GIGTVPIQPF GISYVDDFAE PTNSPLYISI LFAIAVFGPA FGYLLGSVML RIFVDYGRVD
     TATVNLSPGD PRWIGAWWLG LLISSGFLIV TSLPFFFFPR AMSRGAERSV TAEETMQTEE
     DKSRGSLMDF IKRFPRIFLR LLMNPLFMLV VLSQCTFSSV IAGLSTFLNK FLEKQYGATA
     AYANFLIGAV NLPAAALGML FGGILMKRFV FPLQTIPRVA ATIITISMIL CVPLFFMGCS
     TSAVAEVYPP STSSSIHPQQ PPACRRDCSC PDSFFHPVCG DNGVEYVSPC HAGCSSTNTS
     SEASKEPIYL NCSCVSGGSA SAKTGSCPTS CAQLLLPSIF LISFAALIAC ISHNPLYMMV
     LRVVNQDEKS FAIGVQFLLM RLLAWLPAPS LYGLLIDSSC VRWNYLCSGR RGACAYYDND
     ALRNRYLGLQ MVYKALGTLL LFFISWRMKK NREYSLQENT SGLI
//
